Compare Virinchi with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -11.08% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.30
- The company has been able to generate a Return on Equity (avg) of 2.11% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Software Products
INR 208 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.63
-2.99%
0.45
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-17-2012
Risk Adjusted Returns v/s 
Returns Beta
News

Virinchi Ltd Stock Falls to 52-Week Low of Rs 18.02
Shares of Virinchi Ltd, a micro-cap player in the Software Products sector, declined sharply to a fresh 52-week low of Rs.18.02 on 13 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock underperformed its sector by 3.5% and closed the day with a loss of 5.28%, reflecting persistent pressures on the company’s valuation and financial metrics.
Read full news article
Virinchi Ltd is Rated Strong Sell
Virinchi Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 12 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Virinchi Ltd Stock Falls to 52-Week Low Amid Continued Underperformance
Shares of Virinchi Ltd, a player in the Software Products sector, touched a fresh 52-week low of Rs.18.32 today, marking a significant decline amid a broader market downturn and persistent underperformance relative to its peers and benchmark indices.
Read full news article Announcements 
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
09-Mar-2026 | Source : BSEplease find enclosed
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
26-Feb-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vivo Bio Tech Ltd
Announcement under Regulation 30 (LODR)-Allotment
24-Feb-2026 | Source : BSEAllotment of equity shares on conversion of warrants issued on preferential basis.
Corporate Actions 
No Upcoming Board Meetings
Virinchi Ltd has declared 5% dividend, ex-date: 17 Sep 12
No Splits history available
Virinchi Ltd has announced 1:1 bonus issue, ex-date: 21 Mar 22
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2026
Shareholding Compare (%holding) 
Non Institution
17.5803
Held by 0 Schemes
Held by 2 FIIs (0.06%)
Viswanath Kompella (15.03%)
Green Field Meadows Infra Private Limited (2.52%)
49.31%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 24.48% vs -22.54% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 112.21% vs -3,262.79% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -5.53% vs -1.98% in Sep 2024
Growth in half year ended Sep 2025 is -1,082.84% vs -77.63% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -5.94% vs 3.03% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -325.24% vs -55.99% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 0.37% vs -3.82% in Mar 2024
YoY Growth in year ended Mar 2025 is -94.74% vs 6.61% in Mar 2024






